Microparticles and type 2 diabetes

A S Leroyer1, A Tedgui, C M Boulanger

  • 1Institut National de la Santé et de la Recherche Médicale, Inserm unit 689, Cardiovascular Research Center Inserm Lariboisière, 41, bd de la Chapelle, 75475 Paris cedex 10, France.

Diabetes & Metabolism
|April 12, 2008
PubMed

Insights

Microparticles (MPs), released from activated cells, are elevated in diabetes and cardiovascular diseases. These procoagulant vesicles may drive vascular complications through inflammation and thrombosis.

Area of Science:

  • Cardiovascular Biology
  • Endocrinology
  • Cell Biology

Background:

  • Cell activation or apoptosis releases microparticles (MPs), which are extracellular vesicles containing cell-specific oxidized phospholipids and proteins.
  • MPs are present in healthy blood but elevated in diseases like cardiovascular disease, reflecting cellular injury and vascular dysfunction.
  • Elevated MPs, especially from endothelial cells, serve as a marker for vascular dysfunction.

Purpose of the Study:

  • To investigate the role of microparticles in the pathogenesis of vascular complications in diabetes.
  • To explore how MPs contribute to inflammation, thrombosis, endothelial dysfunction, and angiogenesis in diabetic vascular disease.

Main Methods:

  • Analysis of circulating microparticle levels in healthy individuals and patients with diabetes.
  • Characterization of the molecular cargo (phospholipids, proteins) of microparticles.
  • In vitro studies assessing the effects of MPs on target cells, including pro-inflammatory responses, thrombosis, endothelial function, and angiogenesis.

Main Results:

  • Circulating microparticle levels are elevated in individuals with diabetes.
  • MPs possess procoagulant properties due to exposed phospholipids and tissue factor.
  • MPs stimulate pro-inflammatory responses, promote thrombosis, endothelial dysfunction, and angiogenesis in target cells.

Conclusions:

  • Elevated microparticle levels are associated with diabetes and may indicate vascular dysfunction.
  • Microparticles play a significant role in the development of vascular complications in diabetes.
  • MPs represent a potential therapeutic target for managing diabetic vascular disease.

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...